Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?
Angiotensin II receptor blockers are antihypertensive medications demonstrating some benefits in the treatment of high-risk arterial hypertension (AH). Principal clinical trials’ results are presented; organo-protective action of this drug class, with irbesartan as an example, is demonstrated for AH...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1274 |
| _version_ | 1797882775319085056 |
|---|---|
| author | V. V. Fomin S. V. Moiseev E. A. Saginova |
| author_facet | V. V. Fomin S. V. Moiseev E. A. Saginova |
| author_sort | V. V. Fomin |
| collection | DOAJ |
| description | Angiotensin II receptor blockers are antihypertensive medications demonstrating some benefits in the treatment of high-risk arterial hypertension (AH). Principal clinical trials’ results are presented; organo-protective action of this drug class, with irbesartan as an example, is demonstrated for AH and Type 2 diabetes mellitus combination treatment. |
| first_indexed | 2024-04-10T03:41:06Z |
| format | Article |
| id | doaj.art-ebde305e81c34c99923bd2b67aba7d4b |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:41:06Z |
| publishDate | 2007-06-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-ebde305e81c34c99923bd2b67aba7d4b2023-03-13T07:23:13Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252007-06-0163126131985Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?V. V. Fomin0S. V. Moiseev1E. A. Saginova2Московская медицинская академия им. И.М. СеченоваМосковская медицинская академия им. И.М. СеченоваМосковская медицинская академия им. И.М. СеченоваAngiotensin II receptor blockers are antihypertensive medications demonstrating some benefits in the treatment of high-risk arterial hypertension (AH). Principal clinical trials’ results are presented; organo-protective action of this drug class, with irbesartan as an example, is demonstrated for AH and Type 2 diabetes mellitus combination treatment.https://cardiovascular.elpub.ru/jour/article/view/1274артериальная гипертония высокого рискасахарный диабет 2 типаблокаторы рецепторов ангиотензина iiирбесартан |
| spellingShingle | V. V. Fomin S. V. Moiseev E. A. Saginova Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers? Кардиоваскулярная терапия и профилактика артериальная гипертония высокого риска сахарный диабет 2 типа блокаторы рецепторов ангиотензина ii ирбесартан |
| title | Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers? |
| title_full | Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers? |
| title_fullStr | Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers? |
| title_full_unstemmed | Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers? |
| title_short | Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers? |
| title_sort | arterial hypertension and type 2 diabetes mellitus any benefits for angiotensin ii receptor blockers |
| topic | артериальная гипертония высокого риска сахарный диабет 2 типа блокаторы рецепторов ангиотензина ii ирбесартан |
| url | https://cardiovascular.elpub.ru/jour/article/view/1274 |
| work_keys_str_mv | AT vvfomin arterialhypertensionandtype2diabetesmellitusanybenefitsforangiotensiniireceptorblockers AT svmoiseev arterialhypertensionandtype2diabetesmellitusanybenefitsforangiotensiniireceptorblockers AT easaginova arterialhypertensionandtype2diabetesmellitusanybenefitsforangiotensiniireceptorblockers |